Home
Zoe Harcombe writes:
"The story
On June 7th 2016 overweight and obese people were given a hope – a false hope – that their weight will simply be injected away.
“Fast forward ten years, obesity won’t be a problem. They’ll have the injections, they will be painless, no side-effects and actually really inexpensive and freely available.” Sir Steve Bloom, Professor of Medicine at Imperial College, London.
A miracle injection to end the obesity epidemic. How marvellous!
Something else you should know about Sir Bloom is that a company called Thiakis was founded in 2004 “to develop novel medicines for the treatment of obesity and co-morbidities based on original research of Professor Steve Bloom and his colleagues at Imperial College London.” The main product range being developed was “synthetic versions of the natural gastrointestinal peptide oxyntomodulin”. Look at the bottom line of text: “Wyeth Pharmaceuticals acquires Thiakis in a transaction worth up to £100m.”
That’s a sum worth raving about a product for. It wasn’t mentioned on the Horizon programme, which covered the story on June 7th 2016. "
Read more of the article here ... http://www.zoeharcombe.com/2016/06/obesity-injection-horizon-prog/
you will see it ends
" Or, to use Bloom’s own words, but just to change the subject: “Fast forward ten years, obesity won’t be a problem. They’ll have the low carb diets, they will be painless, no side-effects and actually really inexpensive and freely available.”
Now that really would be a miracle!"
"The story
On June 7th 2016 overweight and obese people were given a hope – a false hope – that their weight will simply be injected away.
“Fast forward ten years, obesity won’t be a problem. They’ll have the injections, they will be painless, no side-effects and actually really inexpensive and freely available.” Sir Steve Bloom, Professor of Medicine at Imperial College, London.
A miracle injection to end the obesity epidemic. How marvellous!
Something else you should know about Sir Bloom is that a company called Thiakis was founded in 2004 “to develop novel medicines for the treatment of obesity and co-morbidities based on original research of Professor Steve Bloom and his colleagues at Imperial College London.” The main product range being developed was “synthetic versions of the natural gastrointestinal peptide oxyntomodulin”. Look at the bottom line of text: “Wyeth Pharmaceuticals acquires Thiakis in a transaction worth up to £100m.”
That’s a sum worth raving about a product for. It wasn’t mentioned on the Horizon programme, which covered the story on June 7th 2016. "
Read more of the article here ... http://www.zoeharcombe.com/2016/06/obesity-injection-horizon-prog/
you will see it ends
" Or, to use Bloom’s own words, but just to change the subject: “Fast forward ten years, obesity won’t be a problem. They’ll have the low carb diets, they will be painless, no side-effects and actually really inexpensive and freely available.”
Now that really would be a miracle!"
